Related references
Note: Only part of the references are listed.Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems
Lawrence Toll et al.
PHARMACOLOGICAL REVIEWS (2016)
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ
Remo Guerrini et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
The nociceptin receptor (NOPR) and its interaction with clinically important agonist molecules: a membrane molecular dynamics simulation study
Gugan Kothandan et al.
MOLECULAR BIOSYSTEMS (2014)
Novel Cyclic Biphalin Analogue with Improved Antinociceptive Properties
Adriano Mollica et al.
ACS MEDICINAL CHEMISTRY LETTERS (2014)
G Protein-Coupled Receptor Oligomerization Revisited: Functional and Pharmacological Perspectives
Sergi Ferre et al.
PHARMACOLOGICAL REVIEWS (2014)
An Immunocytochemical-Derived Correlate for Evaluating the Bridging of Heteromeric Mu-Delta Opioid Protomers by Bivalent Ligands
Ajay S. Yekkirala et al.
ACS CHEMICAL BIOLOGY (2013)
Class A G-Protein-Coupled Receptor (GPCR) Dimers and Bivalent Ligands
Christine Hiller et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Structure of the δ-opioid receptor bound to naltrindole
Sebastien Granier et al.
NATURE (2012)
Structure of the human κ-opioid receptor in complex with JDTic
Huixian Wu et al.
NATURE (2012)
Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic
Aaron A. Thompson et al.
NATURE (2012)
Crystal structure of the μ-opioid receptor bound to a morphinan antagonist
Aashish Manglik et al.
NATURE (2012)
Design Strategies for Bivalent Ligands Targeting GPCRs
Jeremy Shonberg et al.
CHEMMEDCHEM (2011)
Synthesis, biological evaluation and structural characterization of novel glycopeptide analogues of nociceptin N/OFQ
Gemma Arsequell et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2011)
Truncated G protein-coupled mu opioid receptor MOR-1 splice variants are targets for highly potent opioid analgesics lacking side effects
Susruta Majumdar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Heterodimerization of ORL1 and Opioid Receptors and Its Consequences for N-type Calcium Channel Regulation
Rhian M. Evans et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Pharmacological profile of NOP receptors coupled with calcium signaling via the chimeric protein Gαqi5
Valeria Camarda et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2009)
GPCR homomers and heteromers: A better choice as targets for drug development than GPCR monomers?
Vicent Casado et al.
PHARMACOLOGY & THERAPEUTICS (2009)
The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential
David G. Lambert
NATURE REVIEWS DRUG DISCOVERY (2008)
Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series
DJ Daniels et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Synthesis and biological studies of nociceptin derivatives containing the DTPA chelating group for further labeling with therapeutic radionuclides
M Ligeti et al.
PEPTIDES (2005)
Opioid receptor homo- and heterodimerization in living cells by quantitative bioluminescence resonance energy transfer
DX Wang et al.
MOLECULAR PHARMACOLOGY (2005)
The interaction of highly helical structural mutants with the NOP receptor discloses the role of the address domain of nociceptin/orphanin FQ
T Tancredi et al.
CHEMISTRY-A EUROPEAN JOURNAL (2005)
The nociceptin pharmacophore site for opioid receptor binding derived from the NMR structure and bioactivity relationships
MJ Orsini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
A role for heterodimerization of μ and δ opiate receptors in enhancing morphine analgesia
I Gomes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Nonpeptide/peptide chimeric ligands for the nociceptin/orphanin FQ receptor: design, synthesis and in vitro pharmacological activity
R Guerrini et al.
JOURNAL OF PEPTIDE RESEARCH (2004)
UCSF chimera - A visualization system for exploratory research and analysis
EF Pettersen et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Molecular modelling studies on the ORL1-receptor and ORL1-agonists
BM Bröer et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2003)
International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology
RR Neubig et al.
PHARMACOLOGICAL REVIEWS (2003)
Dimerization of morphine and orphanin FQ/nociceptin receptors: generation of a novel opioid receptor subtype
YX Pan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
[Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor
G Calo et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
[Arg(14), Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies
D Rizzi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Characterisation and comparison of novel ligands for the nociceptin/orphanin FQ receptor
E Hashiba et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2001)
Highly potent nociceptin analog containing the Arg-Lys triple repeat
K Okada et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
(8-naphthalen-1-ylmethyl-4-oxo-1-phenyl-1,3,8-triaza-spiro[4.5]-dec-3-yl)-acetic acid methyl ester (NNC 63-0532) is a novel potent nociceptin receptor agonist
C Thomsen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Nociceptin/orphanin FQ receptor ligands
G Calo et al.
PEPTIDES (2000)
Share Paper
